tiprankstipranks
Positive Outlook for ACADIA Pharmaceuticals Driven by Strong Daybue Sales and Promising Pipeline
PremiumRatingsPositive Outlook for ACADIA Pharmaceuticals Driven by Strong Daybue Sales and Promising Pipeline
13d ago
Acadia Pharmaceuticals price target lowered to $37 from $39 at Citizens JMP
Premium
The Fly
Acadia Pharmaceuticals price target lowered to $37 from $39 at Citizens JMP
13d ago
Positive Outlook for ACADIA Pharmaceuticals: Strategic Growth and Promising Metrics Drive Buy Rating
Premium
Ratings
Positive Outlook for ACADIA Pharmaceuticals: Strategic Growth and Promising Metrics Drive Buy Rating
13d ago
Acadia Pharmaceuticals reports Q4 EPS 86c, consensus 22c
PremiumThe FlyAcadia Pharmaceuticals reports Q4 EPS 86c, consensus 22c
14d ago
Acadia Pharmaceuticals sees FY25 revenue $1.03B-$1.095B, consensus $1.05B
Premium
The Fly
Acadia Pharmaceuticals sees FY25 revenue $1.03B-$1.095B, consensus $1.05B
14d ago
Acadia Pharmaceuticals initiated with a Hold at Deutsche Bank
Premium
The Fly
Acadia Pharmaceuticals initiated with a Hold at Deutsche Bank
29d ago
Guggenheim downgrades Acadia Pharmaceuticals to Neutral on lack of catalysts
PremiumThe FlyGuggenheim downgrades Acadia Pharmaceuticals to Neutral on lack of catalysts
2M ago
Acadia Pharmaceuticals downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Acadia Pharmaceuticals downgraded to Neutral from Buy at Guggenheim
2M ago
CompoSecure to spin off Resolute, EHang raises Q4 revenue view; Morning Buzz
Premium
The Fly
CompoSecure to spin off Resolute, EHang raises Q4 revenue view; Morning Buzz
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100